Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting symbols : Sgen save search
Seagen Highlights First Solid Tumor Data for an ADCETRIS® (brentuximab vedotin) Immunotherapy Combination and Preclinical Data for Novel CD30-Directed Antibody-Drug Conjugate at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2023-11-03 (Crawled : 17:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
cd30 adcetris cancer tumor preclinical immunotherapy meeting
Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
Published: 2023-08-16 (Crawled : 13:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.42%
tukysa breast cancer trial
Seagen to Highlight Data From Oncology Portfolio and Pipeline at the 2023 American Society of Clinical Oncology Annual Meeting
Published: 2023-04-26 (Crawled : 22:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.33%
H: 0.22%
C: -0.56%
pipeline meeting
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting
Published: 2023-04-18 (Crawled : 21:00) - mindmed.co
MNMD | $8.87 2.19% 2.31% 1.1M
|
n/a
|
| O: -1.36%
H: 5.66%
C: 5.25%
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: 0.06%
H: 0.21%
C: -0.58%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.12%
H: 0.32%
C: 0.12%
INCY | $51.65 -0.52% -0.58% 2.5M
|
Health Technology
|
| O: -0.18%
H: 0.22%
C: 0.19%
FBRX 4 | $0.7386 2.58% 1.61% 4.7K
|
Health Technology
|
| O: -0.94%
H: 3.81%
C: 0.95%
meeting
Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeutics at the 2023 AACR Annual Meeting
Published: 2023-03-14 (Crawled : 23:00) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.22%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.68%
H: 0.55%
C: 0.42%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
preclinical meeting therapeutics cancer
Seagen to Highlight ADCETRIS® (brentuximab vedotin) Clinical Progress at the 2022 American Society of Hematology (ASH) Annual Meeting
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.07%
H: 1.06%
C: -0.37%
adcetris meeting
Seagen to Highlight New Research from its Diverse Pipeline of Targeted Cancer Therapy Candidates at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -1.69%
H: 0.1%
C: -3.37%
research immunotherapy meeting therapy cancer
Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
GNMSF | News | $290.34 0.23% 3.83% 340
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | News | $28.56 -1.42% -1.51% 530K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - globenewswire.com
GNMSF | News | $290.34 0.23% 3.83% 340
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | News | $28.56 -1.42% -1.51% 530K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
RemeGen to Present Three Studies on Disitamab Vedotin at 2022 ASCO Annual Meeting
Published: 2022-05-24 (Crawled : 03:00) - prnewswire.com
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -2.0%
H: 0.0%
C: -3.8%
asco
Seagen to Highlight Data from Expanding Oncology Portfolio at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-28 (Crawled : 13:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -2.53%
H: 0.29%
C: -0.24%
Seagen to Highlight Two Novel Antibody-Drug Conjugates (ADCs) at the SITC 36th Annual Meeting
Published: 2021-11-09 (Crawled : 14:15) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.25%
H: 0.0%
C: 0.0%
antibody drug
Seagen to Highlight Multiple ADCETRIS® (brentuximab vedotin) Data Presentations at the Upcoming 2021 American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-04 (Crawled : 16:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.02%
H: 1.56%
C: 1.33%
presentation ema
Seagen Announces Long-Term Results from TUKYSA® (tucatinib) Pivotal Trial in Patients with HER2-Positive Breast Cancer During the Virtual Scientific Program of the 2021 ASCO Annual Meeting
Published: 2021-06-03 (Crawled : 12:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.23%
H: 0.23%
C: -0.55%
positive results cancer breast cancer trial her2+ her2- her2
Astellas to Present Data from Expanding Oncology Portfolio During the 2021 ASCO Annual Meeting
Published: 2021-05-17 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.15% 20M
|
Health Technology
|
| O: 0.12%
H: 0.82%
C: 0.1%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -1.06%
H: 3.25%
C: 1.4%
Seagen to Showcase Data from Growing Oncology Portfolio During Virtual Scientific Program of the 2021 ASCO Annual Meeting
Published: 2021-04-29 (Crawled : 13:00) - biospace.com/
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.08%
H: 0.56%
C: -3.74%
growing
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.